Overview

Cariprazine Pediatric ASD PK Study

Status:
Recruiting

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

Summary

This study will be a multi-center, open-label, parallel-group, multiple-dose study in up to 24 male and female participants aged 5 through 17 years, inclusive, with Autism Spectrum Disorder (ASD). The 24 participants will be enrolled into 1 of 4 cohorts (6 participants per cohort).

Phase:

Phase 1

Details

Lead Sponsor:

Allergan

Treatments:

Cariprazine